TIDMKMK

RNS Number : 5747L

Kromek Group PLC

06 September 2023

6 September 2023

Kromek Group plc

("Kromek" or the "Group")

Update on Revolving Credit Facility

Kromek (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments , provides the following update on the revolving credit facility ("RCF") with HSBC.

In the full year results statement issued on 24 July 2023, Kromek stated that the repayment date of its GBP5.0m RCF with HSBC was extended by the bank to 31 August 2023. The Group is pleased to announce that the repayment date has been extended to 30 September 2023 as the Group finalises terms to refinance the borrowing facility.

Kromek will make a further announcement in due course.

For further information, please contact:

 
Kromek Group plc 
Arnab Basu, CEO 
 Paul Farquhar, CFO                             +44 (0)1740 626 060 
 
finnCap Ltd (Nominated Adviser and Joint 
 Broker) 
Geoff Nash/Seamus Fricker/George Dollemore 
 - Corporate Finance 
 Tim Redfern/Charlotte Sutcliffe - ECM          +44 (0)20 7220 0500 
 
Cenkos Securities plc (Joint Broker) 
Giles Balleny - Corporate Finance 
 Michael Johnson/Tamar Cranford-Smith - Sales   +44 (0)20 7397 8900 
 
Gracechurch Group (Financial PR) 
Harry Chathli/Claire Norbury/Henry Gamble       +44 (0)20 4582 3500

Kromek Group plc

Kromek Group plc is a leading developer of radiation detection and bio-detection technology solutions for the advanced imaging and CBRN detection segments. Headquartered in County Durham, UK, Kromek has manufacturing operations in the UK and US, delivering on the vision of enhancing the quality of life through innovative detection technology solutions.

The advanced imaging segment comprises the medical (including CT and SPECT), security and industrial markets. Kromek provides its OEM customers with detector components, based on its core cadmium zinc telluride (CZT) platform, to enable better detection of diseases such as cancer and Alzheimer's, contamination in industrial manufacture and explosives in aviation settings.

In CBRN detection, the Group provides nuclear radiation detection solutions to the global homeland defence and security market. Kromek's compact, handheld, high-performance radiation detectors, based on advanced scintillation and solid-state readout technology, are primarily used to protect critical infrastructure, events, personnel and urban environments from the threat of 'dirty bombs'.

The Group is also developing bio-security solutions in the CBRN detection segment. These consist of fully automated and autonomous systems to detect a wide range of airborne pathogens.

Kromek is listed on AIM, a market of the London Stock Exchange, under the trading symbol 'KMK'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCUNSKROVUKRRR

(END) Dow Jones Newswires

September 06, 2023 06:00 ET (10:00 GMT)

Kromek (LSE:KMK)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Kromek Charts.
Kromek (LSE:KMK)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Kromek Charts.